MiNK Therapeutics, Inc. reported its financial results for the quarter ended September 30, 2025, on November 14, 2025, via a press release and a conference call, although it failed to file this 8-K report on time. The event is significant as it includes key financial data but does not mention any revisions to previously reported results.